Mattia Bernardinetti
Overview
Explore the profile of Mattia Bernardinetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vetrugno L, Boero E, Berchialla P, Forfori F, Bernardinetti M, Spadaro S, et al.
Anaesth Crit Care Pain Med
. 2024 Oct;
43(6):101432.
PMID: 39369987
Background And Objective: We hypothesize that lung ultrasound scores (LUS) can help stratify the cardiac risk of elderly patients undergoing orthopedic surgery for hip fracture, adding value to the Revised...
2.
Meani P, Lorusso R, Kowalewski M, Isgro G, Cazzaniga A, Satriano A, et al.
Front Cardiovasc Med
. 2022 Aug;
9:970334.
PMID: 36035925
Background: The effectiveness of veno-arterial extracorporeal life support (V-A ECLS) in treating neonatal and pediatric patients with complex congenital heart disease (CHD) and requiring cardio-circulatory assistance is well-known. Nevertheless, the...
3.
Vetrugno L, Boero E, Bignami E, Cortegiani A, Raineri S, Spadaro S, et al.
Ultrasound J
. 2021 Jun;
13(1):30.
PMID: 34100124
Background: Hip fracture is one of the most common orthopedic causes of hospital admission in frail elderly patients. Hip fracture fixation in this class of patients is considered a high-risk...
4.
Vetrugno L, Tomasino S, Battezzi A, Parisella L, Bernardinetti M, Bove T
Tumori
. 2019 Jun;
104(6):NP14-NP16.
PMID: 31248337
Purpose: In patients with cutaneous graft versus host disease (GvHD) that is resistant to traditional steroid therapy, imatinib is a first-generation tyrosine kinase inhibitor that seems to be a viable...
5.
Ruberto F, Bergantino B, Testa M, DArena C, Bernardinetti M, Diso D, et al.
Int J Artif Organs
. 2015 Jan;
37(12):911-7.
PMID: 25588765
Background: Low-flow extracorporeal CO2 removal devices are easy to setup and manage and may provide valuable ventilation support. Methods: We employed a new device (ProLUNG) recently introduced into the clinical...